FDC116115: A prospective study of sexual function in sexually active men treated for BPH

Trial Profile

FDC116115: A prospective study of sexual function in sexually active men treated for BPH

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Dutasteride/tamsulosin (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 16 Oct 2017 Primary endpoint of total MSHQ scores at month 12 has been met, according to results published in the BJU International.
    • 16 Oct 2017 Results published in the BJU International
    • 23 Apr 2016 This trial is completed in Germany (end date: 5 Apr 2016), according to European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top